113 related articles for article (PubMed ID: 3020248)
21. Interaction of palytoxin and cardiac glycosides on erythrocyte membrane and (Na+ + K+) ATPase.
Ozaki H; Nagase H; Urakawa N
Eur J Biochem; 1985 Oct; 152(2):475-80. PubMed ID: 2865137
[TBL] [Abstract][Full Text] [Related]
22. Origin of differences of inhibitory potency of cardiac glycosides in Na+/K+-transporting ATPase from human cardiac muscle, human brain cortex and guinea-pig cardiac muscle.
Schönfeld W; Schönfeld R; Menke KH; Weiland J; Repke KR
Biochem Pharmacol; 1986 Oct; 35(19):3221-31. PubMed ID: 3021166
[TBL] [Abstract][Full Text] [Related]
23. Isoform-specific stimulation of cardiac Na/K pumps by nanomolar concentrations of glycosides.
Gao J; Wymore RS; Wang Y; Gaudette GR; Krukenkamp IB; Cohen IS; Mathias RT
J Gen Physiol; 2002 Apr; 119(4):297-312. PubMed ID: 11929882
[TBL] [Abstract][Full Text] [Related]
24. Influence of derivation on the lipophilicity and inhibitory actions of cardiac glycosides on myocardial Na+-K+-ATPase.
Dzimiri N; Fricke U; Klaus W
Br J Pharmacol; 1987 May; 91(1):31-8. PubMed ID: 3036289
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of 2-hydroxy derivatives of digitoxigenin and 3-epidigitoxigenin.
Gobbini M; Marazzi G; Padoani G; Quadri L; Valentino L; Zappavigna MP; Melloni P
Bioorg Med Chem; 1998 Oct; 6(10):1889-94. PubMed ID: 9839018
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of the alpha1beta1 isoform of the Na, K-ATPase by 8-methoxycoumestrol without positive inotropic effect in human myocardium--novel aspects of cardiac glycoside pharmacology.
Potter T; Hauck C; Pôças ES; Diedrichs H; Adam C; Reuter H; Wittwer T; Wahlers T; da Silva AJ; Costa PR; Noël F; Müller-Ehmsen J
J Cardiovasc Pharmacol; 2009 Jul; 54(1):10-5. PubMed ID: 19487957
[TBL] [Abstract][Full Text] [Related]
27. Interaction between cardiotonic steroids and Na,K-ATPase. Effects of pH and ouabain-induced changes in enzyme conformation.
Cornelius F; Mahmmoud YA
Biochemistry; 2009 Oct; 48(42):10056-65. PubMed ID: 19778013
[TBL] [Abstract][Full Text] [Related]
28. Structure-activity relationships of an aminosugar cardiac glycoside, ASI-222 HCl, in the heart-lung preparation of the dog.
Cook LS; Caldwell RW; Nash CB
J Cardiovasc Pharmacol; 1979; 1(5):551-9. PubMed ID: 94411
[TBL] [Abstract][Full Text] [Related]
29. 17 alpha-O-(aminoalkyl)oxime derivatives of 3 beta,14 beta-dihydroxy-5 beta-androstane and 3 beta-hydroxy-14-oxoseco-D-5 beta-androstane as inhibitors of Na(+),K(+)-ATPase at the digitalis receptor.
Gobbini M; Barassi P; Cerri A; De Munari S; Fedrizzi G; Santagostino M; Schiavone A; Torri M; Melloni P
J Med Chem; 2001 Nov; 44(23):3821-30. PubMed ID: 11689068
[TBL] [Abstract][Full Text] [Related]
30. Structure-activity relationships of saponins and cardiac glycosides. III. Beta-L-xylopyranosyl-(1-->6)-alpha- and -beta-D-glucopyranosides.
Takechi M; Uno C; Tanaka Y
Biol Pharm Bull; 1998 Nov; 21(11):1234-5. PubMed ID: 9853422
[TBL] [Abstract][Full Text] [Related]
31. Photoaffinity labeling of erythrocyte membrane (Na+ + K+)-ATPase with high specific activity [125I]iodoazidogalactosyl digitoxigenin.
Lowndes JM; Hokin-Neaverson M; Ruoho AE
Biochim Biophys Acta; 1987 Nov; 904(1):154-8. PubMed ID: 2822112
[TBL] [Abstract][Full Text] [Related]
32. Na+/K+-transporting ATPase as a tool in the synthetic further development of cardioactive steroids.
Repke KR; Weiland J
Pharmacol Res Commun; 1988 Jun; 20(6):425-50. PubMed ID: 2843934
[No Abstract] [Full Text] [Related]
33. Synthesis of 20-hydroxy-, 20-amino-, and 20-nitro-14-hydroxy-21-nor-5 beta,14 beta-pregnane C-3 glycosides and related derivatives: structure-activity relationships of pregnanes that bind to the digitalis receptor.
Templeton JF; Ling Y; Zeglam TH; LaBella FS
J Med Chem; 1993 Jan; 36(1):42-5. PubMed ID: 8421289
[TBL] [Abstract][Full Text] [Related]
34. Revisiting the binding kinetics and inhibitory potency of cardiac glycosides on Na
Noël F; Azalim P; do Monte FM; Quintas LEM; Katz A; Karlish SJD
J Pharmacol Toxicol Methods; 2018; 94(Pt 2):64-72. PubMed ID: 30244071
[TBL] [Abstract][Full Text] [Related]
35. Involvement of the sugar moiety in the inhibitory action of the cardiac glycosides on the palytoxin-induced responses in vascular smooth muscles.
Ozaki H; Nagase H; Urakawa N
J Pharmacol Exp Ther; 1984 Oct; 231(1):153-8. PubMed ID: 6149301
[TBL] [Abstract][Full Text] [Related]
36. Structure-activity relationships of progesterone derivatives that bind to the digitalis receptor: modifications in A and B rings.
Templeton JF; Kumar VP; Kim RS; LaBella FS
Steroids; 1987; 49(4-5):383-96. PubMed ID: 3455050
[TBL] [Abstract][Full Text] [Related]
37. The current concept for the cardiac glycoside receptor.
Bodemann HH
Clin Cardiol; 1981; 4(5):223-8. PubMed ID: 6273035
[TBL] [Abstract][Full Text] [Related]
38. Effects of K+ on the interaction between cardiac glycosides and Na,K-ATPase.
Akera T; Ng YC; Shieh IS; Bero E; Brody TM; Braselton WE
Eur J Pharmacol; 1985 May; 111(2):147-57. PubMed ID: 2990948
[TBL] [Abstract][Full Text] [Related]
39. Structural studies on the biosides of Digitalis lanata: bisdigitoxosides of digitoxigenin, gitoxigenin and digoxigenin.
Go KT; Bhandary KK
Acta Crystallogr B; 1989 Jun; 45 ( Pt 3)():306-12. PubMed ID: 2619961
[TBL] [Abstract][Full Text] [Related]
40. Active compounds in Chinese herbs and medicinal animal products which promote blood circulation via inhibition of Na+, K+-ATPase.
Tzen JT; Chen RJ; Chung TY; Chen YC; Lin NH
Chang Gung Med J; 2010; 33(2):126-36. PubMed ID: 20438664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
